Empty Capsules Market by Product, Raw Material, Therapeutic Application and End User - Global Opportunity Analysis and Industry Forecast, 2017-2025

  • ID: 4603671
  • Report
  • Region: Global
  • 267 pages
  • Allied Analytics LLP
1 of 4
Empty Capsules Market by Product {Gelatin Capsules (Hard Gelatin Capsules (HGCs) & Soft Gelatin Capsules (SGCs)) and Non-gelatin Capsules}, Raw Material (Pig Meat, Bovine Meat, Bones, HPMC, and Other Raw Materials), Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent Preparations, Cardiac Therapy Drugs, and Other Applications), and End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers, and Other End Users) - Global Opportunity Analysis and Industry Forecast, 2017-2025

The global empty capsules market was valued at $1,841.5 million in 2017 and is expected to reach $3,707.5 million by 2025, registering a CAGR of 9.1% from 2018 to 2025. Capsules are defined as hard or soft containers that can enclose medicines in a particular dosage form. The popularity of capsule drug delivery form has increased in the recent years because capsules act as relatively stable shells protecting the active pharmaceutical ingredients (APIs) and enable targeted drug delivery.

The demand for both gelatin and non-gelatin capsules for oral consumption has increased over the years. Non-gelatin capsules majorly comprise hydroxypropyl methylcellulose (HPMC), which acts as an ideal substitute for gelatin capsules. The consumption of both gelatin and HPMC capsules are significantly high across the globe because they eliminate the need for fillers. In 2014, about 10–15% of the supplements and medications launched in the U.S. were in the form of capsules. This is a gigantic increase from the previous figure of 5% in 2007. Over a span of time, gelatin capsules have become an ideal the choice of capsules among pharmaceutical manufacturers and nutraceutical manufacturers. Gelatin dissolves easily, and is therefore an ideal option for encapsulation of medicines as well as supplements. In addition, gelatin is highly compatible with other ingredients used in drug formulations and contains proteins that can be easily digested in the gastrointestinal tract.

Factors, such as rise in the geriatric population who are more susceptible to acute and chronic ailments, increase in demand for capsules over other drug delivery forms, and high inclination of patients toward non-invasive treatments for cardiac disorders propel the market growth. However, rise in the prices of gelatin as a raw material and ethical issues associated with its procurement are expected to hamper the market growth. Innovative capsule drug delivery technologies introduced in the market are anticipated to open new avenues in the global empty capsules market in the near future.

The global empty capsules market is segmented based on product, raw material, therapeutic application, end user, and region. Based on product, the market is bifurcated into gelatin and non-gelatin capsules. The gelatin capsules are further divided into hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs). According to raw material, the market is divided into pig meat, bovine meat, bones, HPMC, and other raw materials. On the basis of therapeutic application, the market is classified into antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and other applications. The end users of the industry are broadly categorized into pharmaceutical manufacturers, nutraceutical manufacturers, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, CIS (Commonwealth of Independent States), and MENA (Middle East and North Africa).

KEY BENEFITS:

The study provides an in-depth analysis of the global empty capsules market along with the current trends and future estimations to elucidate the imminent investment pockets.
A Comprehensive analysis of the factors that drive and restrict the market growth is included in the study.
A Comprehensive quantitative analysis of the industry for the period of 2016-2023 is provided to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry is provided to understand the trends in the empty capsules industry, worldwide.
The profiles of key players along with their strategies are provided to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS:

By Product

Gelatin Capsule
Hard Gelatin Capsule (HGC)
Soft Gelatin Capsule (SGC)
Non-gelatin Capsule

By Raw Material

Pig Meat
Bovine Meat
Bone
HPMC
Other Raw Materials

By Therapeutic Application

Antibiotic & Antibacterial Drug
Vitamin & Dietary Supplement
Antacids & Anti-flatulent Preparation
Cardiac Therapy Drug
Other Applications

By End User

Pharmaceutical Manufacturer
Nutraceutical Manufacturer
Other End Users

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
CIS
Russia
Kazakhstan
Azerbaijan
Rest of CIS
MENA
Saudi Arabia
Iran
UAE
Algeria
Egypt
Rest of MENA

KEY MARKET PLAYERS

ACG Worldwide
Bright Pharma Caps, Inc.
CapsCanada Corporation
Lonza Group Ltd. (Capsugel)
Medi-Caps Ltd.
Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
Roxlor LLC.
Snail Pharma Industry Co. Ltd.
Suheung Co., Ltd.
Sunil Healthcare Ltd.

The other players in the value chain include (profiles not included in the report)

Patheon Ltd.
Nectar Lifesciences Ltd.
JC Biological Technologies
Natural Capsules Ltd.
Zhejiang Huili Capsules Co., Ltd.
Healthcaps India Limited
HTC Group Limited
Nanjing Saturn Pharmaceutical Technology Co., Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Porters Five Forces analysis
3.3. Key findings
3.3.1. Top investment pockets, 2017
3.3.2. Top player positioning, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in popularity of capsules over other drug delivery forms
3.4.1.2. Increase in strategic collaboration between empty capsule suppliers and gelatin manufacturers
3.4.1.3. Rise in advancements in the development of capsules
3.4.2. Restraints
3.4.2.1. Ethical concerns along with the price fluctuations regarding gelatin material
3.4.2.2. Stringent regulations in pharmaceutical industry
3.4.3. Opportunity
3.4.3.1. Developing economies offer lucrative opportunities

CHAPTER 4: EMPTY CAPSULES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Gelatin Capsules
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. Hard Gelatin Capsules (HGCs)
4.2.4.1. Market Size and Forecast
4.2.5. Soft Gelatin
4.2.5.1. Market Size and Forecast
4.3. Non-Gelatin
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

CHAPTER 5: EMPTY CAPSULES MARKET, BY RAW MATERIAL
5.1. Overview.
5.1.1. Market size and forecast
5.2. Pig Meat
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Bovine Meat
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Bone
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. HPMC
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Other Raw Materials
5.6.1. Market size and forecast
5.6.2. Market analysis, by country

CHAPTER 6: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION
6.1. Overview.
6.1.1. Market size and forecast
6.2. Antibiotic & Antibacterial Drugs
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Vitamin & Dietary Supplements
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Antacids & Anti-flatulent Preparations
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Cardiac Therapy Drugs
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Other Applications
6.6.1. Market size and forecast
6.6.2. Market analysis, by country

CHAPTER 7: EMPTY CAPSULES MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Pharmaceuticals Manufacturers
7.2.1. Market size and forecast
7.2.2. Market analysis, by country
7.3. Nutraceutical Manufacturers
7.3.1. Market size and forecast
7.3.2. Market analysis, by country
7.4. Other End Users
7.4.1. Market size and forecast
7.4.2. Market analysis, by country

CHAPTER 8: EMPTY CAPSULES MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. North America market size and forecast, by country
8.2.2.1. U.S. market size and forecast, by product
8.2.2.2. U.S. market size and forecast, by raw material
8.2.2.3. U.S. market size and forecast, by therapeutic application
8.2.2.4. U.S. market size and forecast, by end user
8.2.2.5. Canada market size and forecast, by product
8.2.2.6. Canada market size and forecast, by raw material
8.2.2.7. Canada market size and forecast, by therapeutic application
8.2.2.8. Canada market size and forecast, by end user
8.2.2.9. Mexico market size and forecast, by product
8.2.2.10. Mexico market size and forecast, by raw material
8.2.2.11. Mexico market size and forecast, by therapeutic application
8.2.2.12. Mexico market size and forecast, by end user
8.2.3. North America market size and forecast, by product
8.2.4. North America market size and forecast, by raw material
8.2.5. North America market size and forecast, by therapeutic application
8.2.6. North America market size and forecast, by end user
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country
8.3.2.1. Germany market size and forecast, by product
8.3.2.2. Germany market size and forecast, by raw material
8.3.2.3. Germany market size and forecast, by therapeutic application
8.3.2.4. Germany market size and forecast, by end user
8.3.2.5. UK market size and forecast, by product
8.3.2.6. UK market size and forecast, by raw material
8.3.2.7. UK market size and forecast, by therapeutic application
8.3.2.8. UK market size and forecast, by end user
8.3.2.9. France market size and forecast, by product
8.3.2.10. France market size and forecast, by raw material
8.3.2.11. France market size and forecast, by therapeutic application
8.3.2.12. France market size and forecast, by end user
8.3.2.13. Rest of Europe market size and forecast, by product
8.3.2.14. Rest of Europe market size and forecast, by raw material
8.3.2.15. Rest of Europe market size and forecast, by therapeutic application
8.3.2.16. Rest of Europe market size and forecast, by end user
8.3.3. Europe market size and forecast, by product
8.3.4. Europe market size and forecast, by raw material
8.3.5. Europe market size and forecast, by therapeutic application
8.3.6. Europe market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country
8.4.2.1. Japan market size and forecast, by product
8.4.2.2. Japan market size and forecast, by raw material
8.4.2.3. Japan market size and forecast, by therapeutic application
8.4.2.4. Japan market size and forecast, by end user
8.4.2.5. China market size and forecast, by product
8.4.2.6. China market size and forecast, by raw material
8.4.2.7. China market size and forecast, by therapeutic application
8.4.2.8. China market size and forecast, by end user
8.4.2.9. India market size and forecast, by product
8.4.2.10. India market size and forecast, by raw material
8.4.2.11. India market size and forecast, by therapeutic application
8.4.2.12. India market size and forecast, by end user
8.4.2.13. Rest of Asia-Pacific market size and forecast, by product
8.4.2.14. Rest of Asia-Pacific market size and forecast, by raw material
8.4.2.15. Rest of Asia-Pacific market size and forecast, by therapeutic application
8.4.2.16. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific market size and forecast, by product
8.4.4. Asia-Pacific market size and forecast, by raw material
8.4.5. Asia-Pacific market size and forecast, by therapeutic application
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. CIS
8.5.1. Key trends and opportunities
8.5.2. CIS market size and forecast, by country
8.5.2.1. Russia market size and forecast, by product
8.5.2.2. Russia market size and forecast, by raw material
8.5.2.3. Russia market size and forecast, by therapeutic application
8.5.2.4. Russia market size and forecast, by end user
8.5.2.5. Kazakhstan market size and forecast, by product
8.5.2.6. Kazakhstan market size and forecast, by raw material
8.5.2.7. Kazakhstan market size and forecast, by therapeutic application
8.5.2.8. Kazakhstan market size and forecast, by end user
8.5.2.9. Azerbaijan market size and forecast, by product
8.5.2.10. Azerbaijan market size and forecast, by raw material
8.5.2.11. Azerbaijan market size and forecast, by therapeutic application
8.5.2.12. Azerbaijan market size and forecast, by end user
8.5.2.13. Rest of CIS market size and forecast, by product
8.5.2.14. Rest of CIS market size and forecast, by raw material
8.5.2.15. Rest of CIS market size and forecast, by therapeutic application
8.5.2.16. Rest of CIS market size and forecast, by end user
8.5.3. CIS market size and forecast, by product
8.5.4. CIS market size and forecast, by raw material
8.5.5. CIS market size and forecast, by therapeutic application
8.5.6. CIS market size and forecast, by end user
8.6. MENA
8.6.1. Key trends and opportunities
8.6.2. MENA market size and forecast, by country
8.6.2.1. Saudi Arabia market size and forecast, by product
8.6.2.2. Saudi Arabia market size and forecast, by raw material
8.6.2.3. Saudi Arabia market size and forecast, by therapeutic application
8.6.2.4. Saudi Arabia market size and forecast, by end user
8.6.2.5. Iran market size and forecast, by product
8.6.2.6. Iran market size and forecast, by raw material
8.6.2.7. Iran market size and forecast, by therapeutic application
8.6.2.8. Iran market size and forecast, by end user
8.6.2.9. UAE market size and forecast, by product
8.6.2.10. UAE market size and forecast, by raw material
8.6.2.11. UAE market size and forecast, by therapeutic application
8.6.2.12. UAE market size and forecast, by end user
8.6.2.13. Algeria market size and forecast, by product
8.6.2.14. Algeria market size and forecast, by raw material
8.6.2.15. Algeria market size and forecast, by therapeutic application
8.6.2.16. Algeria market size and forecast, by end user
8.6.2.17. Egypt market size and forecast, by product
8.6.2.18. Egypt market size and forecast, by raw material
8.6.2.19. Egypt market size and forecast, by therapeutic application
8.6.2.20. Egypt market size and forecast, by end user
8.6.2.21. Rest of MENA market size and forecast, by product
8.6.2.22. Rest of MENA market size and forecast, by raw material
8.6.2.23. Rest of MENA market size and forecast, by therapeutic application
8.6.2.24. Rest of MENA market size and forecast, by end user
8.6.3. MENA market size and forecast, by product
8.6.4. MENA market size and forecast, by raw material
8.6.5. MENA market size and forecast, by therapeutic application
8.6.6. MENA market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES
9.1. ACG Worldwide
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.2. Bright Pharma Caps Inc.
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Product portfolio
9.2.4. Key strategic moves and developments
9.3. CapsCanada Corporation
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product portfolio
9.3.4. Key strategic moves and developments
9.4. Lonza Group Ltd. (Capsugel)
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Medi-Caps Ltd.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio
9.5.5. Business performance
9.6. Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Roxlor LLC
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.8. Snail Pharma Industry Co. Ltd.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.9. Suheung Co., Ltd.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Product portfolio
9.10. Sunil Healthcare Ltd.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Empty Capsules Market by Product, Raw Material, Therapeutic Application, and End User: Global Opportunity Analysis and Industry Forecast, 20172025, the global empty capsules market was valued at $1,841.5 million in 2017 and is projected to reach $3,707.5 million by 2025 growing at a CAGR of 9.1% from 2018 to 2025. Among raw materials, the pig meat segment accounted for three-sevenths share of the total market in 2017.

Capsules are the second most common form of dosage for the oral administration of drugs after tablets. These are largely used in the nutraceutical and pharmaceutical sectors. Reduction in the timelines of drug development under standard conditions has been the key factor driving the production of drugs delivered in the form of capsules among pharmaceutical and nutraceutical manufacturers. In addition, this strategy enables pharmaceutical manufacturers to reduce the time required to introduce the drug in the market. The other advantage includes protection of a drug substance from various external factors, such as natural or artificial light during production, storage, administration, and use. Furthermore, capsules act as an efficient shield, which prevents the enclosed drugs from decomposition.

Based on the product, the global empty capsules market is classified into gelatin capsules and non-gelatin capsules. Gelatin capsules are further bifurcated into hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs). The gelatin segment dominated the global market in 2017 and is expected to maintain this trend throughout the forecast period. Gelatin has been the standard choice of raw material for the development of hard shell capsules that can efficiently hold active pharmaceutical ingredients (APIs). Whereas, the non-gelatin capsules segment are expected to grow at the fastest pace from 2018 to 2025. An increase in demand for hydroxypropyl methylcellulose (HPMC) capsules is the major contributor to the robust CAGR of the non-gelatin capsules segment in the global market. Furthermore, a major shift in consumer behavior has been observed toward the use of vegetarian capsules in the recent years.

Based on therapeutic application, the market is divided into antibiotic & antibacterial drugs, vitamin & dietary supplements, antacids & anti-flatulent preparations, cardiac therapy drugs, and other applications. The antibiotic & antibacterial drugs segment dominated the global market in 2017 and is anticipated to continue this dominance throughout the forecast period. However, the vitamin & dietary supplements segment is expected to grow at the fastest pace throughout the forecast period. Consumption of antibiotics has considerably increased in the recent years. Increasing consumption of antibiotics, either prescription or over-the-counter, has resulted in incessant use of antibiotics for the treatment of ailments across the globe.

Key Findings of the Empty Capsules Market:

The CIS (Commonwealth of Independent States) region accounted for one-ninth share of the global market in 2017.
The market for cardiac therapy drugs utilizing empty capsules are expected to grow at the second-highest CAGR of 10.4% from 2018 to 2025.
North America dominated the global empty capsules market, accounting for the maximum share in 2017 and is expected to retain a similar trend during the forecast period.
Hydroxypropyl methylcellulose (HPMC) capsules raw material is growing at the fastest pace during the forecast period.
The SGCs segment is estimated to grow at the highest CAGR of 8.1% from 2018 to 2025.

The Asia-Pacific region is expected to witness the highest growth rate throughout the forecast period, owing to its high population base, increase in disposable incomes, improvement in patient awareness toward chronic disorders, and adoption of a healthy lifestyle. In addition, countries, such as India and China, serve as major contributors to the growth of the Asia-Pacific empty capsules market, owing to the continuously evolving pharmaceutical industry in these countries.

The major companies profiled in this report include ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd. (Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co., Ltd, and Sunil Healthcare Ltd. The other prominent players in the value chain include Patheon Ltd., Nectar Lifesciences Ltd., JC Biological Technologies, Natural Capsules Ltd., Zhejiang Huili Capsules Co., Ltd., Healthcaps India Limited, HTC Group Limited, and Nanjing Saturn Pharmaceutical Technology Co., Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll